Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Sahlgrenska University Hospital, Sweden AstraZeneca |
---|---|
Information provided by: | Sahlgrenska University Hospital, Sweden |
ClinicalTrials.gov Identifier: | NCT00718406 |
The primary aim was to evaluate the relief of chest pain during the first 30 minutes among patients who received metoprolol alone as compared with metoprolol plus morphine
Condition | Intervention | Phase |
---|---|---|
Acute Coronary Syndromes |
Drug: Metoprolol Drug: metoprolol plus morphine |
Phase IV |
Study Type: | Interventional |
Arms | Assigned Interventions |
---|---|
A: Active Comparator
A=metoprolol
|
Drug: Metoprolol |
B: Active Comparator
B=metoprolol plus morphine
|
Drug: metoprolol plus morphine |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | S203-02 |
Study First Received: | July 16, 2008 |
Last Updated: | July 16, 2008 |
ClinicalTrials.gov Identifier: | NCT00718406 |
Health Authority: | Sweden: Regional Ethical Review Board |
Acute coronary syndrome Chest pain Betablockers Morphine Prehospital phase |
Morphine Heart Diseases Metoprolol succinate Myocardial Ischemia Acute Coronary Syndrome |
Vascular Diseases Pain Ischemia Metoprolol Chest Pain |
Sympatholytics Neurotransmitter Agents Disease Adrenergic Agents Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Central Nervous System Depressants Narcotics Cardiovascular Agents Antihypertensive Agents Pharmacologic Actions Pathologic Processes |
Sensory System Agents Autonomic Agents Therapeutic Uses Syndrome Adrenergic beta-Antagonists Cardiovascular Diseases Adrenergic Antagonists Analgesics Peripheral Nervous System Agents Anti-Arrhythmia Agents Central Nervous System Agents Analgesics, Opioid |